Levoketoconazole in the Treatment of Patients With Cushing’s Syndrome and Diabetes Mellitus: Results From the SONICS Phase 3 Study

BACKGROUND: Cushing’s syndrome (CS) is associated with numerous comorbidities, including diabetes mellitus (DM). Levoketoconazole, an orally administered ketoconazole stereoisomer, is in clinical trials for the treatment of CS. METHODS: SONICS, a prospective, open-label, phase 3 study in adults with...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Front Endocrinol (Lausanne)
Egile Nagusiak: Pivonello, Rosario, Elenkova, Atanaska, Fleseriu, Maria, Feelders, Richard A., Witek, Przemyslaw, Greenman, Yona, Geer, Eliza B., Perotti, Paola, Saiegh, Leonard, Cohen, Fredric, Arnaldi, Giorgio
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Frontiers Media S.A. 2021
Gaiak:
Endocrinology
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC8059833/
https://ncbi.nlm.nih.gov/pubmed/33897615
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2021.595894
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak